BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev 2020;41:100648. [PMID: 31839434 DOI: 10.1016/j.blre.2019.100648] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Fang LW, Pan H, Shi J. [Ibrutinib treatment for 2 cases of relapsed/refractory autoimmune hemolytic anemia: a pilot study]. Zhonghua Xue Ye Xue Za Zhi 2020;41:412-6. [PMID: 32536139 DOI: 10.3760/cma.j.issn.0253-2727.2020.05.009] [Reference Citation Analysis]
2 Mcknight TF, Diguardo MA, Jacob EK. New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia: Traditional and Novel Tests. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2021.11.003] [Reference Citation Analysis]
3 Gelbenegger G, Jaeger U, Fillitz M, D'sa S, Cartwright R, Shafer F, Wardecki M, Wang J, Schoergenhofer C, Jilma B. Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open‐label, extension trial. Br J Haematol. [DOI: 10.1111/bjh.18289] [Reference Citation Analysis]
4 Michel M. Adult Evans' Syndrome. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2021.12.004] [Reference Citation Analysis]
5 Bestwick JP, Skelly BJ, Swann JW, Glanemann B, Bexfield N, Gkoka Z, Walker DJ, Silvestrini P, Adamantos S, Seth M, Warland J. Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs. J Vet Intern Med 2022. [PMID: 35801263 DOI: 10.1111/jvim.16469] [Reference Citation Analysis]
6 Jain NA, Zhao S, Wei L, Rogers KA, Otterson GA, Wang TF, Owen DH. Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers. Cancer Manag Res 2020;12:11743-9. [PMID: 33235503 DOI: 10.2147/CMAR.S264166] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tsukamoto Y, Umeda M, Muto Y, Sugimoto T, Yamauchi M, Ando K, Ariyoshi K. Severe Anemia Due to Cold Agglutinin Syndrome in a COVID-19 Patient with IgM Monoclonal Gammopathy of Undetermined Significance Successfully Treated with Corticosteroids. Intern Med 2022;61:1789-93. [PMID: 35342131 DOI: 10.2169/internalmedicine.8647-21] [Reference Citation Analysis]
8 Chen M, Zhuang J, Yang C, Zhang L, Wang W, Cai H, Yu Y, Li J, Zhou D, Han B. Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia. Ann Hematol 2020;99:1141-3. [DOI: 10.1007/s00277-020-03976-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Gertz MA. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2021.11.001] [Reference Citation Analysis]
10 Xu J, Wang L, Chen F. Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report. BMC Cardiovasc Disord 2020;20:106. [PMID: 32131747 DOI: 10.1186/s12872-020-01401-8] [Reference Citation Analysis]
11 Barcellini W, Fattizzo B. The Changing Landscape of Autoimmune Hemolytic Anemia. Front Immunol 2020;11:946. [PMID: 32655543 DOI: 10.3389/fimmu.2020.00946] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
12 Davison AS, Luangrath E, Selvi E, Ranganath LR. Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria - Is nitisinone the solution? Mol Genet Metab Rep 2020;23:100588. [PMID: 32322505 DOI: 10.1016/j.ymgmr.2020.100588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Cortesi M, Soresina A, Dotta L, Gorio C, Cattalini M, Lougaris V, Porta F, Badolato R. Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets. Front Immunol 2022;13:846660. [PMID: 35464467 DOI: 10.3389/fimmu.2022.846660] [Reference Citation Analysis]
14 Fattizzo B, Rampi N, Barcellini W. Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors. Pharmaceuticals 2022;15:557. [DOI: 10.3390/ph15050557] [Reference Citation Analysis]
15 Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 2021;21:103016. [PMID: 34915182 DOI: 10.1016/j.autrev.2021.103016] [Reference Citation Analysis]
16 Berentsen S. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Front Immunol 2020;11:590. [PMID: 32318071 DOI: 10.3389/fimmu.2020.00590] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
17 Falvella FS, Chibireva M, Panteghini M. Prospective validation of an automatic reflex test for identifying spurious elevations of mean corpuscular haemoglobin concentration due to the presence of cold agglutinins. Scand J Clin Lab Invest 2021;:1-3. [PMID: 34346820 DOI: 10.1080/00365513.2021.1959051] [Reference Citation Analysis]
18 Barcellini W, Giannotta J, Fattizzo B. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol 2020;13:585-97. [PMID: 32274943 DOI: 10.1080/17474086.2020.1754791] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
19 Wong ASL, Gruber DR, Richards AL, Sheldon K, Qiu A, Hay A, Hudson KE. Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity. J Autoimmun 2020;114:102489. [PMID: 32507505 DOI: 10.1016/j.jaut.2020.102489] [Reference Citation Analysis]
20 Idalan N, Zeitz JO, Weber CN, Müller E, Giger U. Comparative study of immunohematological tests with canine blood samples submitted for a direct antiglobulin (Coombs') test. Canine Med Genet 2021;8:10. [PMID: 34645506 DOI: 10.1186/s40575-021-00107-0] [Reference Citation Analysis]
21 Wu Y, Wu Y, Ji Y, Liang J, He Z, Liu Y, Tang L, Guo G. Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy. Front Med (Lausanne) 2021;8:697192. [PMID: 34485334 DOI: 10.3389/fmed.2021.697192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Wong D, Thomas W, Butler A, Sharkey L. Bortezomib for treatment-refractory autoimmune haemolytic anaemia following multivisceral transplantation. BMJ Case Rep 2021;14:e241634. [PMID: 33980556 DOI: 10.1136/bcr-2021-241634] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sun PL, Jeffery U. Effect of dilution of canine blood samples on the specificity of saline agglutination tests for immune-mediated hemolysis. J Vet Intern Med 2020;34:2374-83. [PMID: 33169867 DOI: 10.1111/jvim.15945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Calhoun B, Moore A, Dickey A, Shoemaker DM. Systemic loxoscelism induced warm autoimmune hemolytic anemia: clinical series and review. Hematology 2022;27:543-54. [PMID: 35544675 DOI: 10.1080/16078454.2022.2065086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tranekær S, Hansen DL, Frederiksen H. Epidemiology of Secondary Warm Autoimmune Haemolytic Anaemia-A Systematic Review and Meta-Analysis. J Clin Med 2021;10:1244. [PMID: 33802848 DOI: 10.3390/jcm10061244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Faraci M, Dellorso G, Giardino S, Pierri F. Autoimmune diseases after allogeneic stem cell transplantation: a clinician's guide and future outlook. Expert Rev Clin Immunol 2022. [PMID: 35500169 DOI: 10.1080/1744666X.2022.2072299] [Reference Citation Analysis]
27 Baur K, Buser AS, Infanti L, Halter JP, Passweg JR, Holbro A. Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions. Lancet Haematol 2021;8:e229-39. [PMID: 33636143 DOI: 10.1016/S2352-3026(20)30404-X] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Anandappa AJ, Stefely JA, Hasserjian RP, Dzik WH, Waheed A. Multiorgan failure in a fatal case of autoimmune hemolytic anemia. Transfusion 2021. [PMID: 34046911 DOI: 10.1111/trf.16513] [Reference Citation Analysis]
29 Ghimire A, Platnich J, Chauhan U. Warm Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia during a Severe COVID-19 B.1.1.7 Infection. Infectious Disease Reports 2022;14:413-9. [DOI: 10.3390/idr14030044] [Reference Citation Analysis]
30 Berentsen S. How I treat cold agglutinin disease. Blood 2021;137:1295-303. [PMID: 33512410 DOI: 10.1182/blood.2019003809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
31 Berentsen S, Barcellini W, D'Sa S, Jilma B. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom? Immunotherapy 2022. [PMID: 35946351 DOI: 10.2217/imt-2022-0085] [Reference Citation Analysis]
32 Wittmann G. [54/f-Dyspnea, yellow sclera and dark-colored urine : Preparation for the medical specialist examination: part 73]. Internist (Berl) 2021;62:482-5. [PMID: 34448013 DOI: 10.1007/s00108-021-01104-y] [Reference Citation Analysis]
33 Wu Y, Wu Y, Ji Y, Liu Y, Wu D, Liang J, Guo G, Chen B. Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies. Front Med (Lausanne) 2021;8:723167. [PMID: 34646843 DOI: 10.3389/fmed.2021.723167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zaninoni A, Fermo E, Vercellati C, Marcello AP, Barcellini W, Bianchi P. Congenital Hemolytic Anemias: Is There a Role for the Immune System? Front Immunol 2020;11:1309. [PMID: 32655575 DOI: 10.3389/fimmu.2020.01309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Jalink M, de Boer ECW, Evers D, Havinga MQ, Vos JMI, Zeerleder S, de Haas M, Jongerius I. Halting targeted and collateral damage to red blood cells by the complement system. Semin Immunopathol 2021. [PMID: 34191092 DOI: 10.1007/s00281-021-00859-8] [Reference Citation Analysis]
36 Sezen M, Yildiz A, Yavuz M, Dilek K, Güllülü M, Oruç A, Aydin MF, Ersoy A. Acute Tubular Necrosis Associated with Autoimmune Hemolytic Anemia due to Acute Gastroenteritis. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.877028] [Reference Citation Analysis]
37 Portich JP, Blos B, Sekine L, Franz JPM. Cold agglutinin syndrome secondary to splenic marginal zone lymphoma: a case report. Hematol Transfus Cell Ther 2021:S2531-1379(21)01289-X. [PMID: 34836848 DOI: 10.1016/j.htct.2021.07.009] [Reference Citation Analysis]
38 Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, Wolny-Rokicka E, Nowakowska E, Gil L. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing 2020;17:38. [PMID: 33292368 DOI: 10.1186/s12979-020-00208-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hansen DL, Möller S, Andersen K, Gaist D, Frederiksen H. Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980-2016. Clin Epidemiol 2020;12:497-508. [PMID: 32547241 DOI: 10.2147/CLEP.S250250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
40 Wang Z, Bo L, Xu Y, Liu H, Zhao Y. Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients. Int J Lab Hematol 2021. [PMID: 33459487 DOI: 10.1111/ijlh.13469] [Reference Citation Analysis]
41 Garg M, Agarwal S, Altohami M. A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report. Br J Haematol 2022. [PMID: 34993954 DOI: 10.1111/bjh.18011] [Reference Citation Analysis]
42 Zaninoni A, Giannotta JA, Gallì A, Artuso R, Bianchi P, Malcovati L, Barcellini W, Fattizzo B. The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease. Front Immunol 2021;12:649441. [PMID: 33732266 DOI: 10.3389/fimmu.2021.649441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Röth A, Fryzek J, Jiang X, Reichert H, Patel P, Su J, Morales Arias J, Broome CM. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion 2021. [PMID: 34813663 DOI: 10.1111/trf.16745] [Reference Citation Analysis]
44 Krull A, Thompson T, Strasburg D, DiGuardo M, Jacob EK. How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease? Transfusion 2022. [PMID: 35946488 DOI: 10.1111/trf.17038] [Reference Citation Analysis]
45 Yui JC, Brodsky RA. Updates in the Management of Warm Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2021.11.005] [Reference Citation Analysis]
46 Ascoli Bartoli T, Lepore L, D'Abramo A, Adamo G, Corpolongo A, Scorzolini L, Giancola ML, Bevilacqua N, Palazzolo C, Mariano A, Ippolito G, Buffet P, Nicastri E. Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis. Malar J 2021;20:206. [PMID: 33926462 DOI: 10.1186/s12936-021-03735-w] [Reference Citation Analysis]
47 Hill QA, Horan M, Charlton A, Bullock T, Massey E, Hill A, Allard S, Stanworth SJ. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience. Br J Haematol 2021;192:e54-7. [PMID: 33216965 DOI: 10.1111/bjh.17217] [Reference Citation Analysis]
48 Gordon MJ, Ferrajoli A. Unusual complications in the management of chronic lymphocytic leukemia. Am J Hematol 2022. [PMID: 35491515 DOI: 10.1002/ajh.26585] [Reference Citation Analysis]
49 Patriquin CJ, Pavenski K. O, wind, if winter comes … will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease. Transfusion 2021. [PMID: 34893982 DOI: 10.1111/trf.16765] [Reference Citation Analysis]
50 Fang S, Yang F. Recurrent infection-induced autoimmune haemolytic anaemia complicated by pulmonary embolism: a case report and literature review. Clin Med (Lond) 2021;21:e306-8. [PMID: 34001586 DOI: 10.7861/clinmed.2021-0112] [Reference Citation Analysis]
51 Murakhovskaya I. Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia. J Clin Med 2020;9:E4034. [PMID: 33322221 DOI: 10.3390/jcm9124034] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Albiol N, Moreno C. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies. Cancer J 2021;27:286-96. [PMID: 34398555 DOI: 10.1097/PPO.0000000000000537] [Reference Citation Analysis]
53 Jaydev F, Kumar V, Khatri J, Shahani S, Beganovic S, Reikvam H. A Case of Autoimmune Hemolytic Anemia after the First Dose of COVID-19 mRNA-1273 Vaccine with Undetected Pernicious Anemia. Case Reports in Hematology 2022;2022:1-5. [DOI: 10.1155/2022/2036460] [Reference Citation Analysis]
54 Mejia Buritica L, Zapata Alvarez J, Vergara Quintero L, Villegas Molina JP, Torres Hernandez JD. Autoimmune Hemolytic Anemia After Cyanocobalamin Replacement in a Patient With a Previous Diagnosis of Pernicious Anemia: A Case Report. Cureus 2020;12:e10797. [PMID: 33163301 DOI: 10.7759/cureus.10797] [Reference Citation Analysis]
55 Audia S, Grienay N, Mounier M, Michel M, Bonnotte B. Evans' Syndrome: From Diagnosis to Treatment. J Clin Med 2020;9:E3851. [PMID: 33260979 DOI: 10.3390/jcm9123851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
56 Barcellini W, Giannotta JA, Fattizzo B. Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature. Front Immunol 2020;11:609198. [PMID: 33574816 DOI: 10.3389/fimmu.2020.609198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
57 Kuter DJ, Rogers KA, Boxer MA, Choi M, Agajanian R, Arnold DM, Broome CM, Field JJ, Murakhovskaya I, Numerof R, Tong S. Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study. Am J Hematol 2022;97:691-9. [PMID: 35179251 DOI: 10.1002/ajh.26508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood 2021;137:1283-94. [PMID: 33512406 DOI: 10.1182/blood.2019003808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Cabo J, Brochier A, Saussoy P, van Dievoet MA, Capirchio L, Delire B, Deneys V. Positive direct antiglobulin test in COVID-19 patients: Decision-making process. Transfus Clin Biol 2021:S1246-7820(21)00081-1. [PMID: 34111506 DOI: 10.1016/j.tracli.2021.05.010] [Reference Citation Analysis]
60 Makharia A, Lakhotia M, Roy B. Primary Evans syndrome in an adult man. BMJ Case Rep 2021;14:e243051. [PMID: 34887288 DOI: 10.1136/bcr-2021-243051] [Reference Citation Analysis]
61 William V, Rusmawatiningtyas D, Makrufardi F, Widjajanto PH. Comprehensive management of refractory autoimmune hemolytic anemia in pediatric beta-thalassemia major patient: A case report. Ann Med Surg (Lond) 2021;70:102853. [PMID: 34691416 DOI: 10.1016/j.amsu.2021.102853] [Reference Citation Analysis]
62 Girard LP, Soekojo CY, Ooi M, Chng WJ, de Mel S. Immunoglobulin M Monoclonal Gammopathies of Clinical Significance. Front Oncol 2022;12:905484. [PMID: 35756635 DOI: 10.3389/fonc.2022.905484] [Reference Citation Analysis]
63 Fattizzo B, Giannotta JA, Serpenti F, Barcellini W. Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist. J Clin Med 2020;9:E3858. [PMID: 33261016 DOI: 10.3390/jcm9123858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
64 Iolascon A, Rivella S, Anagnou NP, Camaschella C, Swinkels D, Muckenthaler MU, Porto G, Barcellini W, Andolfo I, Risitano AM, Kattamis A, Cappellini MD, Taher AT, De Franceschi L, Rees D, Russo R, Tamary H, Stauder R, Girelli D. The EHA Research Roadmap: Anemias. Hemasphere 2021;5:e607. [PMID: 34522846 DOI: 10.1097/HS9.0000000000000607] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ying Q, Lv D, Fu X, Shi S, Chen L, He Y, Yang J, Yang S, Mu Q. Resolution of serologic problems due to cold agglutinin mediated autoimmune hemolytic anemia and its transfusion decision. J Clin Lab Anal 2021;35:e23894. [PMID: 34216510 DOI: 10.1002/jcla.23894] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Yen C, Huang W, Li S, Chen Y, Tseng Y, Yen Y, Chu C, Hsu Y, Chen T. Pure Red Cell Aplasia and Other Haematological Diseases Associated With Thymoma: A Case Series and Systematic Review. Front Med 2021;8:759914. [DOI: 10.3389/fmed.2021.759914] [Reference Citation Analysis]
67 Cavarretta CA, Visentin A, Pravato S, Piva E, Piazza F, Basso D, Trentin L. Anaemia during venetoclax ramp-up phase: Do not forget unusual causes. Int J Lab Hematol 2022. [PMID: 35538897 DOI: 10.1111/ijlh.13875] [Reference Citation Analysis]
68 Chauhan K, Shandilya N. A case of spuriously high MCV with no signs of RBC agglutination. Scandinavian Journal of Clinical and Laboratory Investigation. [DOI: 10.1080/00365513.2022.2030493] [Reference Citation Analysis]
69 Acquaviva G, Nonne G, Murtas A, Longu F, Caocci G, La Nasa G, Fozza C. Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia. Ann Hematol 2021. [PMID: 33469687 DOI: 10.1007/s00277-021-04416-z] [Reference Citation Analysis]
70 Motta I, Giannotta J, Ferraresi M, Barbullushi K, Revelli N, Graziadei G, Barcellini W, Fattizzo B. Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature. J Clin Med 2021;10:3439. [PMID: 34362222 DOI: 10.3390/jcm10153439] [Reference Citation Analysis]
71 Schär DT, Daskalakis M, Mansouri B, Rovo A, Zeerleder S. Thromboembolic complications in autoimmune hemolytic anemia: Retrospective study. Eur J Haematol 2022;108:45-51. [PMID: 34551149 DOI: 10.1111/ejh.13710] [Reference Citation Analysis]
72 Kandinata SG, Soelistijo SA, Amrita PNA. Graves' Disease Presenting as Autoimmune Hemolytic Anemia. Am J Case Rep 2021;22:e930705. [PMID: 33946094 DOI: 10.12659/AJCR.930705] [Reference Citation Analysis]
73 Pasquale R, Giannotta JA, Barcellini W, Fattizzo B. Bortezomib in autoimmune hemolytic anemia and beyond. Ther Adv Hematol 2021;12:20406207211046428. [PMID: 34795889 DOI: 10.1177/20406207211046428] [Reference Citation Analysis]
74 Autore F, Pasquale R, Innocenti I, Fresa A, Sora' F, Laurenti L. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers (Basel) 2021;13:5804. [PMID: 34830959 DOI: 10.3390/cancers13225804] [Reference Citation Analysis]
75 Fazeli B, Ligi D, Keramat S, Maniscalco R, Sharebiani H, Mannello F. Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences. Diagnostics (Basel) 2021;11:1736. [PMID: 34679434 DOI: 10.3390/diagnostics11101736] [Reference Citation Analysis]
76 Venkitakrishnan R, Augustine J, Paul M, Abraham L. Disseminated tuberculosis associated with autoimmune haemolytic anaemia and adrenal deficiency: a rare association. BMJ Case Rep 2022;15:e249277. [PMID: 35246442 DOI: 10.1136/bcr-2022-249277] [Reference Citation Analysis]
77 Hwang SR, Saliba AN, Wolanskyj-Spinner AP. Immunotherapy-associated Autoimmune Hemolytic Anemia. Hematol Oncol Clin North Am 2022;36:365-80. [PMID: 35339260 DOI: 10.1016/j.hoc.2021.11.002] [Reference Citation Analysis]
78 Ursule-Dufait C, Bengoufa D, Theodorou I, Villesuzanne C, Arnulf B. Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease. Br J Haematol 2022. [PMID: 35732557 DOI: 10.1111/bjh.18317] [Reference Citation Analysis]
79 Abdallah GEM, Abbas WA, Elbeih EAS, Abdelmenam E, Mohammed Saleh MF. Systemic corticosteroids in the treatment of warm autoimmune hemolytic anemia: A clinical setting perspective. Blood Cells Mol Dis 2021;92:102621. [PMID: 34808491 DOI: 10.1016/j.bcmd.2021.102621] [Reference Citation Analysis]
80 Kamesaki T. Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up. Transfusion 2021. [PMID: 34668206 DOI: 10.1111/trf.16709] [Reference Citation Analysis]
81 Zhang J, Wang X, Tian JJ, Zhu R, Duo RX, Huang YC, Shen HL. Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report. World J Clin Cases 2022; 10(4): 1286-1290 [DOI: 10.12998/wjcc.v10.i4.1286] [Reference Citation Analysis]
82 Al-shakhshir S, Bannaga A, Kaddam I, Cain O, Haldar D, Armstrong MJ. Jaundice, fever and anaemia: when to avoid the cold. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102147] [Reference Citation Analysis]
83 Bianco C, Coluccio E, Prati D, Valenti L. Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders. J Clin Med 2021;10:423. [PMID: 33499290 DOI: 10.3390/jcm10030423] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Noto A, Cassin R, Mattiello V, Reda G. The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia. J Clin Med 2021;10:2064. [PMID: 34065833 DOI: 10.3390/jcm10102064] [Reference Citation Analysis]
85 Fattizzo B, Cantoni S, Giannotta JA, Bandiera L, Zavaglia R, Bortolotti M, Barcellini W. Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers. Ther Adv Hematol 2022;13:20406207221097780. [PMID: 35585968 DOI: 10.1177/20406207221097780] [Reference Citation Analysis]
86 Fattizzo B, Ferraresi M, Giannotta JA, Barcellini W. Secondary Hemophagocytic Lymphohistiocytosis and Autoimmune Cytopenias: Case Description and Review of the Literature. J Clin Med 2021;10:870. [PMID: 33672504 DOI: 10.3390/jcm10040870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Chetty T, Bouwer N, Wan YO, Mahlangu J. Immunoglobulin subtyping and quantification in direct antiglobulin test: positive haemolysis in an HIV-prevalent setting. J Clin Pathol 2020:jclinpath-2020-207113. [PMID: 33328180 DOI: 10.1136/jclinpath-2020-207113] [Reference Citation Analysis]
88 Pratt G, El‐sharkawi D, Kothari J, D’sa S, Auer R, Mccarthy H, Krishna R, Miles O, Kyriakou C, Owen R. Guidelines on the diagnosis and management of Waldenström macroglobulinaemia—A British Society for Haematology guideline. Br J Haematol. [DOI: 10.1111/bjh.18036] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
89 Iwamoto Y, Anno T, Koyama K, Shirai R, Kaneto H, Tomoda K. Rapidly Exacerbating Autoimmune Hemolytic Anemia Together With Marked Cytokine Storm Triggered by Pneumonia Infection: A Case Report. Front Immunol 2020;11:574540. [PMID: 33042156 DOI: 10.3389/fimmu.2020.574540] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Zhao M, He X, Yang J, Feng Y, Wang H, Shao Z, Xing L. Aberrant microRNA expression in B lymphocytes from patients with primary warm autoimmune haemolytic anaemia. Autoimmunity 2021;54:264-74. [PMID: 34044675 DOI: 10.1080/08916934.2021.1931842] [Reference Citation Analysis]
91 Dores GM, Nayernama A, Cheng C, Moureaud C, Jones SC. Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System. Am J Hematol 2022;97:E129-32. [PMID: 34985778 DOI: 10.1002/ajh.26454] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Gabelli M, Ademokun C, Cooper N, Amrolia PI. Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting. Br J Haematol 2021. [PMID: 34195990 DOI: 10.1111/bjh.17648] [Reference Citation Analysis]
93 Campbell A, Podbury B, Yue M, Mollee P, Bird R, Hapgood G. The Role of a Routine Bone Marrow Biopsy in Autoimmune Hemolytic Anemia for the Detection of an Underlying Lymphoproliferative Disorder. Hemasphere 2022;6:e674. [PMID: 34938958 DOI: 10.1097/HS9.0000000000000674] [Reference Citation Analysis]
94 Gelbenegger G, Schoergenhofer C, Derhaschnig U, Buchtele N, Sillaber C, Fillitz M, Schenk TM, D'Sa S, Cartwright R, Gilbert JC, Jilma B, Jaeger U. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. Blood Adv 2020;4:997-1005. [PMID: 32176765 DOI: 10.1182/bloodadvances.2019001321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
95 Yamada S, Kajikawa S, Nakagawa N, Kondo Y, Okumura H. Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration. Ann Hematol 2021. [PMID: 34448913 DOI: 10.1007/s00277-021-04652-3] [Reference Citation Analysis]
96 Cannata A, Cantoni S, Sciortino A, Bruschi G, Russo CF. Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;77:2323-34. [PMID: 33958130 DOI: 10.1016/j.jacc.2021.03.295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Zagorski E, Pawar T, Rahimian S, Forman D. Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19). Br J Haematol. 2020;Online ahead of print. [PMID: 32460350 DOI: 10.1111/bjh.16892] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
98 Jain A, Gupta DK. Daratumumab for refractory warm autoimmune hemolytic anemia. Ann Hematol 2021;100:1351-3. [PMID: 32405694 DOI: 10.1007/s00277-020-04063-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
99 Capecchi M, Ciavarella A, Artoni A, Abbattista M, Martinelli I. Thrombotic Complications in Patients with Immune-Mediated Hemolysis. J Clin Med 2021;10:1764. [PMID: 33919638 DOI: 10.3390/jcm10081764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
100 Hansen DL, Möller S, Frederiksen H. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up. Eur J Haematol 2022. [PMID: 35276014 DOI: 10.1111/ejh.13764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
101 Mayer S, Srinivasan N, Nguyen J, Spilman R, Scherbak D, Konstantopoulos K. A Curious Case of Hemolytic Anemia with Pseudoreticulopenia. Case Reports in Hematology 2022;2022:1-3. [DOI: 10.1155/2022/6423143] [Reference Citation Analysis]
102 Xiao Z, Murakhovskaya I. Development of New Drugs for Autoimmune Hemolytic Anemia. Pharmaceutics 2022;14:1035. [DOI: 10.3390/pharmaceutics14051035] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Joly F, Schmitt LA, Watson PAM, Pain E, Testa D. The Burden of Cold Agglutinin Disease on Patients’ Daily Life: An Online Survey of 50 American Patients (Preprint). JMIR Formative Research. [DOI: 10.2196/34248] [Reference Citation Analysis]
104 Fattizzo B, Barcellini W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev Clin Immunol 2022;:1-15. [PMID: 35702053 DOI: 10.1080/1744666X.2022.2089115] [Reference Citation Analysis]
105 Barcellini W, Zaninoni A, Giannotta JA, Fattizzo B. New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1. J Clin Med 2020;9:E3859. [PMID: 33261023 DOI: 10.3390/jcm9123859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
106 Tomkins O, Berentsen S, Arulogun S, Sekhar M, D'Sa S. Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy. Am J Hematol 2020. [PMID: 32652632 DOI: 10.1002/ajh.25932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
107 Giannotta JA, Fattizzo B, Cavallaro F, Barcellini W. Infectious Complications in Autoimmune Hemolytic Anemia. J Clin Med 2021;10:E164. [PMID: 33466516 DOI: 10.3390/jcm10010164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
108 Venkatachala RP, Sheela CN, Anandram S, Ross CR. Autoimmune Hemolytic Anaemias in Pregnancy: Experience in a Tertiary Care Hospital in South India. J Obstet Gynaecol India 2021;71:379-85. [PMID: 34566296 DOI: 10.1007/s13224-021-01443-8] [Reference Citation Analysis]
109 Fattizzo B, Bortolotti M, Giannotta JA, Consonni D, Cantoni S, Barcellini W. Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures. Sci Rep 2022;12:7743. [PMID: 35546175 DOI: 10.1038/s41598-022-11857-7] [Reference Citation Analysis]
110 Maffei S, De Guzman M, Rochat R, Tran J, Risen S, Dean A, Coleman N. From Telemedicine to the ICU-Fever and Rash in a 9-Year-Old Girl. Pediatrics 2022;149:e2021051501. [PMID: 34972223 DOI: 10.1542/peds.2021-051501] [Reference Citation Analysis]
111 Rieger MJ, Stolz SM, Ludwig S, Benoit TM, Bissig M, Widmer CC, Schwotzer R, Müller AM, Nair G, Hegemann I, Manz MG, Schanz U. Daratumumab in rituximab-refractory autoimmune haemolytic anaemia. Br J Haematol 2021;194:931-4. [PMID: 34180543 DOI: 10.1111/bjh.17655] [Reference Citation Analysis]